A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if giving the anti-HIV drug nevirapine (NVP) to
HIV-positive pregnant women and their infants can help reduce the chance that a mother will
give HIV to her baby during delivery.
NVP is a promising medication for blocking HIV transmission from HIV-positive mothers to
their infants. NVP is inexpensive and is easily absorbed by the mother and transferred to the
infant. It is thought that even a single dose to the mother and infant may provide enough
protection to the baby during the time of exposure to HIV at birth.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)